Review: The 2022 Mercedes-Benz EQS is a very 'special' electric car

  • 📰 FoxNews
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 87%

Canada Canada Headlines News

Canada Canada Latest News,Canada Canada Headlines

The 2022 Mercedes-Benz EQS is a showcase of the brand's new all-electric platform and the latest safety and luxury technology it has to offer.

Fox News Autos Editor Gary Gastelu says the 2022 Mercedes-Benz EQS lives up to the legacy of the S-Class name.The Mercedes-Benz S-Class has always been a special car.

It’s been used as a showcase for the latest technologies including new engines, airbags, anti-lock brakes and traction control, and the newest"S" follows in that tradition. The EQS starts at $103,360, and no one would call that cheap, but it is around $9,000 less than the lowest-priced S-Class, and that’s before factoring in the $7,500 federal tax credit it qualifies for. An annual estimated fuel savings of $2,700 for a typical driver just keeps racking up the savings. You've got to have money to make money, as they say.The two cars are similar in size, which is enormous, but the EQS has an entirely different look.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 9. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A Potential GSK Game Changer And An MRNA Cancer Vaccine: Highlights From The 2022 ASCO ConferenceI am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account aayushipratap
Source: ForbesTech - 🏆 318. / 59 Read more »